XOMA

$20.80 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About XOMA

XOMA Corporation is a biopharmaceutical company that develops and manufactures genetically engineered protein, peptide, and antibody pharmaceuticals. The Company's medical targets include bacterial and fungal infections, infectious complications, and immunologic and inflammatory disorders. XOMA's primary drug development platform is bactericidal/permeability-increasing protein.

Stock Analysis

last close $20.8
1-mo return 20.5%
3-mo return -25%
avg daily vol. 88.97T
52-week high 39.02
52-week low 16.96
market cap. $202M
forward pe -
annual div. -
roe 15.9%
ltg forecast -
dividend yield -
annual rev. $41M
inst own. 60.3%
baraka

Subscribe now for daily local and international financial news

Subscribe